Proteinuria and Albuminuria During and After Paricalcitol Treatment in Chronic Kidney Disease Patients.

about

Proteinuria and Albuminuria During and After Paricalcitol Treatment in Chronic Kidney Disease Patients.

Item

http://www.wikidata.org/entity/Q40433180

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Proteinuria and Albuminuria Du ...... ronic Kidney Disease Patients.

@en

type

Item

label

Proteinuria and Albuminuria Du ...... ronic Kidney Disease Patients.

@en

prefLabel

Proteinuria and Albuminuria Du ...... ronic Kidney Disease Patients.

@en

P1476

Proteinuria and Albuminuria Du ...... hronic Kidney Disease Patients

@en

P2093

Nina Hojs

http://www.w3.org/2001/XMLSchema#string

Radovan Hojs

http://www.w3.org/2001/XMLSchema#string

Sebastjan Bevc

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Serum cystatin C as an endogenous marker of the renal function--a review.

Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study.

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial.

Estimating glomerular filtration rate from serum creatinine and cystatin C.

Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study.

Out-of-office blood pressure monitoring in chronic kidney disease.

Paricalcitol reduces proteinuria in non-dialysis chronic kidney disease patients.

Serum 25(OH)D and incident type 2 diabetes: a cohort study.

P304

761-768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.660

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert Ekart

P577

2015-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26465921

http://www.w3.org/2001/XMLSchema#string